dc.contributor.author | Price, David | |
dc.contributor.author | Castro, Mario | |
dc.contributor.author | Bourdin, Arnaud | |
dc.contributor.author | Fucile, Sebastian | |
dc.contributor.author | Altman, Pablo | |
dc.date.accessioned | 2020-05-04T08:55:00Z | |
dc.date.available | 2020-05-04T08:55:00Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Price , D , Castro , M , Bourdin , A , Fucile , S & Altman , P 2020 , ' Short-course systemic corticosteroids in asthma : striking the balance between efficacy and safety ' , European respiratory review : an official journal of the European Respiratory Society , vol. 29 , no. 155 , 190151 . https://doi.org/10.1183/16000617.0151-2019 | en |
dc.identifier.issn | 0905-9180 | |
dc.identifier.other | PURE: 162463865 | |
dc.identifier.other | PURE UUID: 7ca342cb-5847-4ee1-b51d-a0807eb58607 | |
dc.identifier.other | PubMed: 32245768 | |
dc.identifier.other | Scopus: 85083041581 | |
dc.identifier.other | WOS: 000528238600014 | |
dc.identifier.uri | https://hdl.handle.net/2164/14232 | |
dc.description | The authors thank Gillian Lavelle and Claire Twomey (Novartis Product Lifecycle Services, Dublin, Ireland) for providing scientific writing support for this article, which was funded by Novartis Pharma AG (Basel, Switzerland) in accordance with Good Publication Practice (GPP3) guidelines (www.ismpp.org/gpp3). | en |
dc.format.extent | 8 | |
dc.language.iso | eng | |
dc.relation.ispartof | European respiratory review : an official journal of the European Respiratory Society | en |
dc.rights | Copyright ©ERS 2020. http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Adrenal Cortex Hormones/adverse effects | en |
dc.subject | Anti-Asthmatic Agents/adverse effects | en |
dc.subject | Asthma/drug therapy | en |
dc.subject | Humans | en |
dc.subject | Morbidity | en |
dc.subject | Risk Factors | en |
dc.subject | Treatment Outcome | en |
dc.subject | GLUCOCORTICOIDS | en |
dc.subject | BONE-MINERAL DENSITY | en |
dc.subject | CHILDREN | en |
dc.subject | IMPACT | en |
dc.subject | ORAL CORTICOSTEROIDS | en |
dc.subject | OUTCOMES | en |
dc.subject | APPROPRIATE USE | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Short-course systemic corticosteroids in asthma : striking the balance between efficacy and safety | en |
dc.type | Journal item | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1183/16000617.0151-2019 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85083041581&partnerID=8YFLogxK | en |
dc.identifier.vol | 29 | en |
dc.identifier.iss | 155 | en |